EML
Home
Recent Updates
Favourites
Search
Directory
Guidelines
Medicines
Tools
About
Feedback
Disclaimer
Directory
Guidelines
Search
Medicines
Tools
Antineoplastic and Immunomodulating Agents
Bevacizumab
ATC Code
Indication
NEMLC Recommendation
Review Indicators
Date Ratified
ATC CODE
L01XC07
INDICATION
Sub-retinal neovascular membranes and non-resolving macular odema.
NEMLC RECOMMENDATION
Approved
(off label indication).
REVIEW INDICATORS
None
DATE RATIFIED
10 December 2015